Moneycontrol Be a Pro
Get App
Last Updated : Aug 20, 2019 11:58 AM IST | Source: Moneycontrol.com

Dr Reddy’s gains on launch of Vigabatrin powder

The company launched Vigabatrin powder in 500 mg per packet, a therapeutic equivalent generic version of Sabril (vigabatrin) powder, approved by the US Food and Drug Administration (USFDA).

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

The Dr Reddy’s Laboratories' stock gained more than a percent intraday on August 20 after the company launched Vigabatrin powder (oral solution).

The company launched Vigabatrin powder in 500 mg per packet, a therapeutic equivalent generic version of Sabril (vigabatrin) powder, approved by the US Food and Drug Administration (USFDA).

The Sabril brand and generic had US sales of approximately USD 274 million MAT for the most recent twelve months ending in June 2019, as per IMS Health.

Close
At 11:01 hours, the stock was quoting Rs 2,539.60, up Rs 29.10, or 1.16 percent on the BSE.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Aug 20, 2019 11:17 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant